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Background: Dissotis thollonii Cogn. belonging to the Malastomataceae family is used in the West Region of
Cameroon for the treatment of inﬂammation, kidney diseases, pregnancy control and sinusitis. Despite the tradi-
tional use of this plant, no scientiﬁc report or informationwas found in the literature regarding neither its biolog-
ical activity nor its chemical constituents.
Aim of the study: The present work was designed to determine the antimicrobial, antioxidant and anti-
inﬂammatory activities of different extracts of the roots of D. thollonii Cogn. as well as the isolation and identiﬁ-
cation of the chemical constituents of this plant.
Materials and methods: The tests for antimicrobial, antioxidant and anti-inﬂammatory activities were performed
over the MeOH, EtOAc, n-BuOH and aqueous extracts. Compounds were isolated from EtOAc and n-BuOH ex-
tracts of the roots of D. thollonii Cogn. through column chromatography and their structures were determined
by means of NMR and MS analysis, and published data.
Results:According to the antimicrobial and antioxidant assays, the EtOAc and n-BuOH extractswere submitted to
further separation and puriﬁcation. This led to the isolation of twelve compounds identiﬁed as 3,3′-di-O-
methylellagic acid 4′-O-β-D-xylopyranoside 1, 3-O-methylellagic acid 4′-O-β-D-arabinopyranoside 2, casuarinin
3, betulinic acid 4, β-sitosterol-3-O-D-glucopyranosyl-6′-mirystate 5, cellobiosylsterol 6, β-sitosterol 7, β-
sitosterol-3-O-β-D-glucopyranoside 8, arjunolic acid 9, 3,3′-di-O-methylellagic acid 10, ellagic acid 11, and
3,3′-di-O-methylellagic acid 4′-O-β-D-glucopyranoside 12. The EtOAc extract was the only antimicrobial active
sample [diameter of the zone of inhibition (DZI) of 10 mm against Staphyloccocus aureus] among all the tested
extracts. The analysis of fractions of this extract revealed the presence of bioactive compounds with a described
antimicrobial activity such as β-sitosterol, β-sitosterol-3-O-β-D-glucopyranoside and arjunolic acid. By using
Trolox as the standard drug, all extracts showed antioxidant activity against DPPH in the following order of scav-
enging ability: Trolox N nBuOH N EtOAc NMeOH NWE(water extract). The ABTS•+ scavenging abilitywas similar
to that found for the DPPH assay, being Trolox N n-BuOH NMeOH N EtOAc NWE. Alongwith the DPPH and ABTS
assays, the FRAP assay showed the scale n-BuOH NMeOH NWE N EtOAc. The phytochemical study of the EtOAc
and n-BuOH extracts revealed the presence of important known antioxidant compounds such as ellagic acid de-
rivatives, arjunolic acid, betulinic acid and β-sitosterol. The anti-inﬂammatory properties of D. thollonii extracts
were investigated using RAW264.7murinemacrophage cells. TheMeOH extract reduced the stimulatedNOpro-
duction in a concentration-dependent manner. 86% reduction was observed at the highest tested concentration
of 100 μg/ml (IC50 = 5.9 μg/ml). The n-BuOH extract showed higher dose dependent reduction of NO formation
(IC50 = 6.5 μg/ml) than the EtOAc extract (IC50 = 18.1 μg/ml), whereas the water extract had no signiﬁcant in-
ﬂuence on the NO production. All the extracts did not have any inﬂuence on the macrophage viability. The phy-
tochemical investigation of the EtOAc and n-BuOH extracts revealed that themain compounds identiﬁed do have
potent anti-inﬂammatory properties.37 33451735.
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20 R.N. Nono et al. / South African Journal of Botany 93 (2014) 19–26Conclusion: The biological and phytochemical characterization of the root extracts ofD. thollonii validates the use
of this plant for the treatment of inﬂammation and sinusitis, thus providing evidence that this plant extracts, as
well as some of the isolated compounds, might be potential sources of antioxidant and anti-inﬂammatory drugs.© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
African populations are confrontedwith chronic diseases emergence
whose treatment and follow-up constitute for them a major economic
problem (Konkon et al., 2008). Of all the alternative modalities, herbal
medicine is probably the most popular and the most ubiquitous
(Akerele, 1993). The World Health Organization has described tradi-
tional herbalmedicine as one of the surestmeans to achieve total health
care coverage of the world's population (Okunlola et al., 2007). In tradi-
tional herbal practice in Africa, indigenous medicinal plants have been
employed in the treatment of several important infections (Taylor
et al., 2001). The Melastomataceae are predominantly pantropical
plants, including approximately 163 genera and 4300 species
(Laís et al., 2011). Many species of this family are known for their
different uses in folk medicine as antioxidant, antihypertensive,
antihyperglycemic, hemostatic, antihepatitis, and antidiarrhoic drugs
(Susanti et al., 2007; Cheng et al., 1993; Amalraj and Ignacimuthu,
1998; Nicholl et al., 2001; Abere et al., 2010). Phytochemical studies of
Melastomataceae plants have indicated an abundance of tannins, poly-
phenols, ﬂavonoids, fatty acids, steroids, and free triterpenoids (Yoshida
et al., 1994; Isaza et al., 2001; Calderón et al., 2002; Ndjateu et al., 2014).
Dissotis thollonii (IPNI, 2012) is used in theWest Region of Cameroon for
the treatment of inﬂammation, kidney diseases, pregnancy control
and sinusitis. Despite the traditional use of this plant, no scientiﬁc
report or information was found in the literature regarding neither its
biological activity nor its chemical constituents. In our continuous
search for bioactive extracts and secondary metabolites from
Cameroonian medicinal plants (Nzowa et al., 2013; Fouedjou et al.,
2014), and with the aim to support the traditional use of D. thollonii,
we undertook the present study to investigate the phytochemistry
and the antimicrobial, antioxidant and anti-inﬂammatory activities of
the roots extracts of D. thollonii.2. Materials and methods
2.1. Plant material
The roots of D. thollonii Cogn. (Melastomataceae) were collected in
Bangoua village near Bangangté (West Region of Cameroon) in Novem-
ber 2011. The plant was identiﬁed at the Cameroon National Herbarium,
Yaoundé, Cameroonwhere a voucher specimenwas deposited under the
reference number 28107/SRF/CAM.2.2. Extraction and isolation
2.2.1. Preparation of extracts
The air-dried andpulverized roots ofD. thollonii (1.8 kg)were extract-
ed three times (each time for 24 h) by maceration with MeOH (11 l) at
room temperature. The ﬁltrate obtained was concentrated under re-
duced pressure to yield a dark crude extract (211 g). Part of this extract
(183 g) was suspended in water (400 ml) and successively extracted
with EtOAc and n-BuOH which were concentrated to dryness under re-
duced pressure to afford EtOAc (21 g) and n-BuOH (28.5 g) extracts, re-
spectively. The aqueous extract was obtained by decoction of 50 g of
roots' powder in 200 ml of distilled water and the ﬁltrate obtained was
concentrated under reduced pressure to yield 7 g of residue. The EtOAc
and n-BuOH extracts were puriﬁed using column chromatography.2.2.2. Isolation of compounds
According to the antimicrobial and antioxidant assays, the EtOAc
and n-BuOH extractswere submitted to further separation and puriﬁca-
tion. Part of the EtOAc extract (18 g) was subjected to column chroma-
tography (CC) over silica gel (hexane-EtOAc with increasing polarity)
and EtOAc-MeOH yielding ﬁve main fractions (A–E). Fraction A (7.0 g)
(hexane-EtOAc 9010 to 80-20) was rechromatographed on silica gel
column using hexane-EtOAc (85-15) to yield compound 7 (40 mg)
and 4 (25 mg). Fraction B (300 mg) (hexane-EtOAc 70-30 to 50-50)
was rechromatographed using hexane-EtOAc (70-30) to yield 5 (20
mg) and 9 (30 mg). Fraction D (1 g) (EtOAc) was subjected to CC over
Sephadex LH-20 gel using MeOH as eluent to yield 1 (15 mg) and 8
(30 mg). Fraction E (5.5 g) was combined mainly on the basis of TLC
to a part of n-BuOH extract (23.5 g) and subjected to CC over silica gel
(EtOAc-MeOH with increasing polarity) yielding seven main fractions
(I–VII). Fraction III (EtOAc) (4.8 g) was rechromatographed on silica
gel column using EtOAc as eluent to yield 10 (4.7 mg) and 11 (5 mg).
Fraction IV (EtOAc-MeOH 95-5) (5.3 g) was subjected to CC over
Sephadex LH-20 using MeOH as eluent to yield 3 (914 mg). Fraction V
(EtOAc-MeOH 95-5) (4.9 g) was rechromatographed over silica gel
using EtOAc-MeOH-H2O 9.5-1-0.5 as eluent to yield subfraction Va,
Vb, Vc and Vd. Sub-fraction Vc (50 mg) was subjected to Sephadex
LH-20 gel CC to yield 6 (8 mg) and 12 (9 mg). Sub-fraction Vd (111
mg) was subjected to silica gel CC using CHCl3-MeOH (90-10) as eluent
to yield 2 (22 mg).
2.3. Structure elucidation and identiﬁcation of the isolated compounds
ESI mass spectra were carried out on an Agilent Technologies LC/
MSD Trap SL (G2445D SL). Samples for NMR experiments were dis-
solved in deteurated solvents (CD3OD, CDCl3, Acetone-d6, D2O and
DMSO-d6) on a varian Mercury plus Spectrometer (400 MHz for 1H
and 100 MHz for 13C). CC was performed on silica gel 60 merck
(0.040–0.063 or 0.063–0.2 mm) and sephadex gel LH-20. Fractions
were monitored by TLC using Merck pre-coated silica gel sheets
(60 F254), and spots were visualized under UV light (254 and
365 nm) and by spraying with 50% H2SO4 and heating at 110 °C.
3,3′-Di-O-methylellagic acid 4′-O-β-D-xylopyranoside 1: yellow
powder, ESIMS (negative-ion mode) exhibited a pseudomolecular ion-
peak at m/z 461.0 [M − H]−, consistent with the molecular formula
C21H18O12. 13C NMR (DMSO-d6, 100 MHz): δ 113.2 (C-1), 142.0 (C-2),
142.3 (C-3), 153.3 (C-4), 112.3 (C-5), 114.9 (C-6), 158.8 (C-7), 112.0
(C-1′), 140.5 (C-2′), 141.4 (C-3′), 151.6 (C-4′), 112.0 (C-5′), 111.5
(C-6′), 158.8 (C-7′), 62.0 (3-OMe), 61.4 (3′-OMe) for aglycone;
102.2 (C-1″), 73.5 (C-2″), 76.5 (C-3″), 69.6 (C-4″), 66.2 (C-5″) for sugar
moiety. 1H NMR (DMSO-d6, 400 MHz) δ 7.52 (1H, s, H-5), 7.76 (1H, s,
H-5′), 4.08 (3H, s, 3-OMe), 4.05 (3H, s, 3′-OMe) for aglycone; 5,15 (1H,
d, J = 7,2 Hz, H-1″) 3.78 (1H, dd, J = 11.2, 5.1 Hz, H-2″), 3.24 (1H, m,
H-3″), 3.39 (1H, m, H-4″), 3.83 (1H, m, H-5″a), 3.38 (1H, m, H-5″b) for
sugar moiety.
3-O-methylellagic acid 4′-O-β-D-arabinopyranoside 2: yellow
powder, 13C NMR (DMSO-d6, 100 MHz) δ 140.5 (C-3), 11.2 (C-5),
160.5 (C-7), 150.0 (C-4′), 118.4 (C-5′), 159.5 (C-7′), 60.8 (3-OMe)
for aglycone; 106.5 (C-1″), 73.6 (C-2″), 76.8 (C-3″), 69.6 (C-4″), 66.5
(C-5″) for sugar moiety. 1H NMR (DMSO-d6, 400 MHz) δ 7.49 (1H, s,
H-5), 7.41 (1H, s, H-5′), 3.93 (3H, s, 3-OMe) for aglycone; 4.45 (1H, br,
H-1″), 3.15 (1H, m, H-2″), 3.15 (1H, m, H-3″), 3.28 (1H, m, H-4″), 3.75
(1H, m, H-5″a), 3.08 (1H, m, H-5″b) for sugar moiety.
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934.7 [M− H]− consistent with the molecular formula C41H28O26; in
this spectrum, we observe the peak at m/z 170.4 [C7H5O5 + H]− and
m/z 301.0 [C14H5O8]−. 13C NMR (Acetone-d6 + D2O, 100 MHz) δ 66.6
(C-1), 75.9 (C-2), 68.6 (C-3), 73.3 (C-4), 70.3 (C-5), 63.6 (C-6) glucose
moiety. 116.1, 119.6, 137.6, 142.8, 145.3 (C-1 HHDP moiety); 104.6,
145.7, 134.2, 115.5, 168.8 (C-3 HHDP (hexahydrodiphenoyl) moiety);
107.5, 144.4, 135.9, 115,5, 167.8 (C-4 HHDP moiety); 119.9, 109.1,
145.1, 138.2, 145.1, 109.1, 164.9 (C-5 galloyl moiety); 114.5, 135.0,
144.5, 168.0 (C-6 HHDP moiety); 163.7, 168.8, 167.8, 164.9, 168.0
(respectively for ester carbonyls in C-2, C-3, C-4, C-5 and C-6). 1H NMR
(Acetone-d6, 400 MHz) δ 5.62 (1H, d, J = 5.4 Hz, H-1), 4.65 (1H,
dd, J = 1.5, 4.9 Hz, H-2), 5.40 (1H, m, H-3), 5,41 (1H, m, H-4), 5.32
(1H, dd, J = 2.5, 8.8 Hz, H-5), 4.04 (1H, m, H-6a), 4.81 (1H, dd, J =
3.4, 12.2 Hz, H-6b) glucose moiety; 6.48 (1H, s, C-3 HHDP moiety),
6.53 (1H, s, C-6 HHDP moiety), 6.78 (1H, s, C-4 HHDP moiety), 7.09
(2H, s, galloyl-H).
Betulinic acid 4: white powder. 13C NMR (CD3OD, 100 MHz) δ 38.5
(C-1), 26.6 (C-2), 78.2 (C-3), 38.6 (C-4), 55.4 (C-5), 18.0 (C-6), 34.2
(C-7), 40.5 (C-8), 50.6 (C-9), 36.9 (C-10), 20.6 (C-11), 25.5 (C-12),
38.3 (C-13), 42.2 (C-14), 30.3 (C-15), 31.9 (C-16), 56.1 (C-17), 46.9
(C-18), 49.1 (C-19), 150.5 (C-20), 29.4 (C-21), 36.7 (C-22), 27.1 (C-23),
14.6 (C-24), 15.2 (C-25), 15.2 (C-26), 13.7 (C-27), 178.5 (C-28), 108.6
(C-29), 18.1 (C-30). 1H NMR (CD3OD, 400 MHz) δ 0.92 (1H, m, H-1a),
1.68 (1H, m, H-1b), 1.54 (2H, m, H-2), 3.11 (1H, dd, J = 5.0, 10.9 Hz),
0.70 (1H, m, H-5), 1.41 (1H, m, H-6b), 1.53 (1H, m, H-6a), 1.39 (2H, m,
H-7), 10.31 (1H, m, H-9), 1.42 (1H, m, H-11a),1.25 (1H, m, H-11b),
1.04 (1H, m, H-12a), 1.70 (1H, m, H-12b), 2,34 (1H, m, H-13), 1.37
(1H, m, H-15a), 1.92 (1H, m, H-15b), 1.40 (1H, m, H-16a), 2.22 (1H, m,
H-16b), 1.62 (1H, m, H-18), 3.30 (1H, ddd, J = 5.0, 16.9, 10.6 Hz,
H-19), 1.43 (1H, m, H-22a), 1.89 (1H, m, H-22-b), 0.95 (3H, s, H-23),
0.75 (3H, s, H-24), 0.97 (1H, s, H-25), 0.86 (3H, s, H-26), 1,00 (3H, s,
H-27), 4.58 (1H, m, H-29a), 4.71 (1H, m, H-29b), 1.68 (3H, s, H-30).
β-Sitosterol-3-O-β-D-glucopyranosyl-6′-mirystate 5:white powder.
ESIMS (negative-ion mode) m/z 803.5 [M + H]−, 413 [C29H49O]−. 13C
NMR (CDCl3, 100 MHz) δ 37.2 (C-1), 32.0 (C-2), 79.6 (C-3), 38.8 (C-4),
140.2 (C-5), 122.1 (C-6), 31.9 (C-7), 31.8 (C-8), 50.1 (C-9), 36.6
(C-10), 21.1 (C-11), 39.8 (C-12), 42.1 (C-13), 56.7 (C-14), 24.8
(C-15), 28.3 (C-16), 56.1 (C-17), 11.8 (C-18), 19.4 (C-19), 36.2
(C-20), 18.8 (C-21), 33.9 (C-22), 26.1 (C-23), 45.9 (C-24), 29.1
(C-25), 19.8 (C-26), 19.1 (C-27), 23.1 (C-28), 12.0 (C-29) for agly-
cone; 101.3 (C-1′), 76.1 (C-2′), 73.9 (C-3′), 73.5 (C-4′), 70.1 (C-5′),
63.3 (C-6′) for sugar moiety; 174.6 (C-1″), 34.2 (C-2″), 24.25 (C-3″),
26.13 (C-4″-C-13″), 14.13 (C-14″) for mirystate moiety; 1H NMR
(CDCl3, 400 MHz) δ 3.53 (1H, m, H-3), 2.25 (1H, m, H-4), 2.35 (1H,
m, H-4b), 5.35 (1H, m, H-6),1.25 (1H, m, H-8), 0.90 (1H, m, H-9),
0.97 (1H, m, H-14) for aglycone; 4.37 (1H, m, H-1′), 3.55 (H-2′),
3.44 (H-3′), 3.35 (H-4′), 3.37 (H-5′), 4.29 (H-6a′), 4.43 (H-6b′) for
sugar moiety; 2.34 (2H, m, H-2″), 1.60 (2H, m, H-3″), 1.13 (CH2
group H-4″ to H-13″), 0,67 (3H, m, H-14″) for mirystate moiety.
Cellobiosylsterol 6:white powder. 13C (DMSO-d6 + D2O, 100 MHz)
δ 37.4 (C-1), 29.3 (C-2), 77.6 (C-3), 141.0 (C-5), 122.0 (C-6), 32.1 (C-7),
50.2 (C-9), 36.1 (C-10), 21.4 (C-11), 39.0 (C-12), 42.53 (C-13), 56.8
(C-14), 28.4 (C-16), 56.0 (C-17), 12.3 (C-18), 19.3 (C-19), 36.8 (C-20),
34.0 (C-22), 45.8 (C-24), 26.0 (C-25), 19.6 (C-26), 19.6 (C-27), 23.2
(C-28), 12.4 (C-29) for aglycone; 100.8 (C-1′), 74.4 (C-2′), 88.5 (C-3′),
70.4 (C-4′), 77.7 (C-5′), 61.7 (C-6′), 104.6 (C-1″), 72.8 (C-2″), 76.7
(C-3″), 69.0 (C-4″), 76.9 (C-5″), 61.1 (C-6″) for sugar moieties. 1H
NMR (DMSO-d6 + D2O, 400 MHz) δ 3.45 (1H, m, H-3), 5.30 (1H, m,
H-6), 1.25 (1H, m, H-8), 0.90 (1H, m, H-9), 0.97 (1H, m, H-14) for
aglycone; 4.32 (1H, d, J = 7.7 Hz, H-1′), 3.01 (1H, m, H-2′), 3.00
(1H, m, H-4′), 4.29 (1H, d, J = 7.7 Hz, H-1″), 3.07 (1H, m, H-2″),
3.13 (1H, m, H-4″) for sugar moieties.
β-Sitosterol 7: 13C (CDCl3, 100 MHz) δ 37.3 (C-1), 31.6 (C-2), 71.8
(C-3); 42.2 (C-4), 140.8 (C-5), 121.7 (C-6), 31.9 (C-7), 31.9 (C-8), 51.2
(C-9), 36.5 (C-10), 21.1 (C-11), 39.8 (C-12), 42.3 (C-13), 56.8 (C-14),24.3 (C-15), 28.3 (C-16), 56.0 (C-17), 11.9 (C-18), 19.4 (C-19), 36.2
(C-20), 18.8 (C-21), 33.9 (C-22), 26.1 (C-23), 45.9 (C-24), 29.2 (C-25),
19.8 (C-26), 19.3 (C-27), 23.1 (C-28), 12.2 (C-29). 1H (CD3Cl,
400 MHz) δ 3.52 (1H, m, H-3), 5.35 (1H, brs, H-6), 0.92 (3H, d, J =
6.4 Hz, H-21), 0.81 (3H, d, J = 6.5 Hz, H-26), 0.83 (3H, d, J = 6.5 Hz),
0.85 (3H, t, H-29).
β-Sitosterol-3-O-β-D-glucopyranoside 8: 13C (CDCl3, 100 MHz)
δ 37.3 (C-1), 30.2 (C-2), 78.5 (C-3); 39.2 (C-4), 140.8 (C-5), 121.7 (C-6),
31.9 (C-7), 31.9 (C-8), 51.2 (C-9), 36.5 (C-10), 21.1 (C-11), 39.8 (C-12),
42.3 (C-13), 56.8 (C-14), 24.3 (C-15), 28.3 (C-16), 56.0 (C-17), 11.9
(C-18), 19.4 (C-19), 36.2 (C-20), 18.8 (C-21), 33.9 (C-22), 26.1 (C-23),
45.9 (C-24), 29.2 (C-25), 19.8 (C-26), 19.3 (C-27), 23.1 (C-28), 12.2
(C-29) for aglycone, 102.5 (C-1′), 75.3 (C-2′), 78.6 (C-3′), 71.6 (C-4′),
78.1 (C-5′), 62.5 (C-6′) for sugar moiety. 1H (CD3Cl, 400 MHz) δ 0.66-
1.25 (CH3 groups), 3.50 (1H, m, H-3), 5.35 (1H, m, H-5) for aglycone;
5.02 (1H, d, J = 7.5 Hz, H-1′) representing the anomeric proton of the
sugar.
Arjunolic acid 9:white powder. 13C (CD3OD, 100MHz) δ 47.8 (C-1),
69.6 (C-2), 78.1 (C-3), 43.0 (C-4), 48.3 (C-5), 19.1 (C-6), 33.8 (C-7), 40.7
(C-8), 48.1 (C-9), 38.5 (C-10), 24.0 (C-11), 123.4 (C-12), 145.3 (C-13),
42.7 (C-14), 29.1 (C-15), 24.4 (C-16), 47.6 (C-17), 43.3 (C-18), 44.1
(C-19), 31.6 (C-20), 34.8 (C-21), 33.5 (C-22), 66.2 (C-23), 13.9 (C-24),
17.7 (C-25), 17.5 (C-26), 26.4 (C-27), 181.8 (C-28), 25.3 (C-29), 24.6
(C-30). 1H (CD3OD, 400 MHz) δ 3.66 (1H, m, H-2), 3.36 (1H, m, H-2),
5.23 (1H, m, H-12), 3.50 (1H, m, H-23a), 3.31 (1H, m, H-23b), 0,69
(3H, s, H-24), 0,81 (3H, s, H-25), 0,91 (3H, s, H-26), 1,17 (3H, s, H-27),
1,03 (3H, s, H-29), 0,94 (3H, s, H-30).
3,3′-Di-O-methylellagic acid 10: yellow powder. 13C NMR (DMSO-d6,
100 MHz) δ 112.1 (C-1; C-1′), 141.9 (C-2; C-2′), 140.9 (C-3; C-3′); 152.5
(C-4; C-4′), 112.37 (C-5; C-5′), 112.8 (C-6; C-6′), 159.1 (C-7; C-7′), 61.6
(3; 3′-OMe). 1H NMR (DMSO-d6, 400 MHz) δ 4.05 (6H, s, 3; 3′-OMe),
7.50 (2H, s, H-5; H-5′).
Ellagic acid 11: yellow powder. 13C NMR (DMSO-d6, 100 MHz)
δ 112.2 (C-1; C-1′), 136.3 (C-2; C-2′), 139.4 (C-3; C-3′), 148.0 (C-4;
C-4′), 110.2 (C-5; C-5′), 107.6 (C-6; C-6′), 159.0 (C-7; C-7′). 1H NMR
(DMSO-d6, 400 MHz) δ 7.05 (2H, s, H-5 and H-5′).
3,3′-Di-O-methylellagic acid 4′-O-β-D-glucopyranoside 12: yellow
powder. 13C NMR (DMSO-d6, 400 MHz) δ 111.9 (C-1), 140.9 (C-2),
140.5 (C-3), 151.3 (C-4), 112.0 (C-5), 112.8 (C-6), 158.5 (C-7), 114.4
(C-1′), 141.7 (C-2′), 141.8 (C-3′), 154.2 (C-4′), 112.8 (C-5′), 112.9
(C-6′), 158.5 (C-7′), 60.9 (3-OMe), 61.5 (3′-OMe) for aglycone;
101.3 (C-1″), 73.3 (C-2″), 77.2 (C-3″), 69.7 (C-4″), 76.4 (C-5″), 60.5
(C-6″) for sugar moiety. 1H NMR (DMSO-d6, 400 MHz) δ 7.51 (1H, s,
H-5), 7.81 (1H, s, H-5′), 4.05 (3H, s, 3-OMe), 4.09 (1H, s, 3′-OMe) for
aglycone; 5.14 (1H, d, J = 7.5 Hz, H-1″), 3.45 (1H, m, H-2″), 3.44 (1H,
m, H-3″), 3.26 (1H, m, H-4″), 3.44 (1H, m, H-5″), 3.73 (1H, m, H-6″a),
3.54 (1H, m, H-6″b) for sugar moiety.2.4. Antimicrobial activity
Microorganisms included in this study were: Staphylococcus S. aureus
ATCC (American Type Culture Collection) 25923, Escherichia coli ATCC
25922, Pseudomonas aeruginosa ATCC 27853, Enterococcus faecalis
ATCC 29212, Candida albicans ATCC 24433. Antimicrobial activity was
assessed by disc diffusion test as reported by the European Committee
for Antimicrobial Susceptibility testing (EUCAST, www.eucast.org).
0. 2 mg of each extract was included in paper discs by spotting 10 μl
of extract solution (0.02 mg/μl), while the known antimicrobials
ciproﬂoxacin (0.5 μg/μl disc) and ﬂuconazole (2.5 μg/μl disc) were
used as a reference against bacteria and fungi, respectively. Activity
was determined by measuring the diameter of the growth inhibition
zone (inhibition zone diameter, IZD) visible around the paper disc
(expressed in mm). Reported IZDs are inclusive of the paper disc diam-
eter (6mm). Therefore, a 6mm IZDmeans no activity. Tests were run in
duplicates.
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The antioxidant activity of the extracts was determined in terms of
hydrogen donating or radical scavenging ability, using the stable radical
DPPH (1,1-diphenyl-2-picrylhydrazyl), on a microplate analytical assay
according to the procedures described by Srinivasan et al. (2007). The
total antioxidant activity of D. thollonii extracts was measured by ABTS
(2′,2′-azinobis(3-ethylbenzothiazline-6-sulfonic acid) radical cation
decolorization assay according to the method of Re et al. (1999) de-
scribed for application to a 96-wellmicroplate assay. Ferric reducing an-
tioxidant capacity assay (FRAP assay) was carried out according to the
procedure described by Müller et al. (2011) by monitoring the reduc-
tion of Fe3+-2,4,6-tri[2-pyridyl-s-triazine] (TPTZ), to blue-colored
Fe2+-TPTZ. The ability of the samples tested to scavenge the different
radicals in the assays was compared to trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid) used as standard. The activities
of D. thollonii extracts were expressed as tocopherol-equivalent antiox-
idant capacity μmol TE/g of product.
2.6. Anti-inﬂammatory activity
2.6.1. RAW 264.7 cell culture
Murine macrophage cell line RAW 264.7 was cultured in Dulbecco's
Modiﬁed Eagle's Medium (DMEM) with 2 mM L-glutamine, 100 IU/ml
penicillin, 100 μg/ml streptomycin, and supplemented with 10% heat-
inactivated foetal bovine serum (HI-FBS) (PAA Laboratories GmbH,
Austria). Cells were cultured in a humidiﬁed atmosphere at 37 °C in
the presence of 5% CO2. Cells were counted with a hemocytometer,
and the number of viable cells was determined by trypan blue dye ex-
clusion (Shin et al., 2004).
2.6.2. Assay for NO production by activated macrophages
RAW264.7macrophageswere seeded in 96well plates at a density of
5 × 105 cells/ml in the presence ofD. thollonii extracts (6.25–100 μg/ml).
Cells were incubated with 1 μg/ml lipopolysaccaride (LPS), alone or co-
incubated with extracts and 1 μg/ml LPS for 24 h. 200 μM
aminoguanidine plus 1 μg/ml LPS served as a control for the reduction
of NO-production (Koh et al., 2009). NO production was determined by
measuring the amount of the primary stable reaction product nitrite
with Griess reagent (Huygen, 1970) (1% sulfanilamide, 0.1% naphthyl-
ethylenediamine-dihydrochloride, 5% H3PO4) by mixing 50 μl of cell cul-
ture supernatant with the same volume of reagents. After incubation for
10min at room temperature, the absorption of the formed diazo dyewas
measured spectrophotometrically at 540 nm using a Titertek Multiscan
microElisa (Labsystems, Helsinki, Finland). The nitrite concentration
was determined by comparison with a sodium nitrite standard calibra-
tion curve in culture medium (0–100 μM).
The cell viability of the macrophages was determined by MTT assay
(Mosmann, 1983). After removal of the cell culture supernatant for ni-
trite measurement, each well received 5 μl of 3-(4,5-dimethylthiozol-2-
yl)-2,5-diphenyl-tetrazolium bromide (MTT) (5 mg/ml in phosphate-
buffered saline, PBS) and the plates were incubated for 4 h at 37 °C. To
dissolve formazan crystals, the MTT solution was removed and 100 μl
of DMSO was added to each well. After 10 min incubation at room tem-
perature the absorbance was measured spectrophotometrically at
540 nm using a Titertek Multiscan microElisa (Labsystems, FI-Helsinki).
Experiments were conducted in triplicate.
2.6.3. Statistical analysis
All assays were conducted at least three times with three different
sample preparations. All data are expressed as themean± standard de-
viation (SD). Analysis of variance was performed in InStat, GraphPad
software, San Diego, CA, USA. A one-way ANOVA with Dunnett's post
hoc testing was used for these analyses, and p b 0.05 was considered
to be statistically signiﬁcant.3. Results and discussion
3.1. Phytochemical analysis
The structures of the isolated compounds were established using
spectroscopic analysis, especially, NMR spectra in conjunction with 2D
experiments, COSY, HSQC, HMBC, and direct comparison with pub-
lished information andwith authentic samples obtained by our research
group for some cases. The twelve compounds isolated from the roots of
D. thollonii (Fig. 1) were identiﬁed as 3,3′-di-O-méthylellagic acid 4′-O-
β-D-xylopyranoside 1 (Xing-Cong et al., 1999), 3-O-méthylellagic
acid 4′-O-β-D-arabinopyranoside 2, casuarinin 3 (Morio et al., 2008),
betulinic acid 4 (Janeczko et al., 1990), β-sitosterol-3-O-β-D-
glucopyranosyl-6′-mirystate 5, cellobiosylsterol 6 (Bankeu et al.,
2010), β-sitosterol 7 (Saeidnia et al., 2011) and β-sitosterol-3-O-β-D-
glucopyranoside 8 (Saeidnia et al., 2011), arjunolic acid 9 (Kundu and
Mahato, 1993), 3,3′-di-O-methylellagic acid 10 (Da Silva et al., 2008),
ellagic acid 11 (Xing-Cong et al., 1999; Guan et al., 2007), and 3,3′-di-
O-methylellagic acid 4′-O-β-D-glucopyranoside 12 (Guan et al., 2007).
3.2. Antimicrobial activity
The extracts assayed for antimicrobial activity were the MeOH ex-
tract (1st step), the EtOAc extract (2nd step), and n-BuOH extract
from the aqueous residue of the second step. The activity of the water
extract was also assessed. The only measurable activity was observed
for the EtOAc extract against the bacterial species S. aureuswith an inhi-
bition zone diameter of 10 ± 1mm. The analysis of fractions of this ex-
tract revealed the presence of bioactive compounds with a described
antimicrobial activity, such as compound 7 (β-sitosterol), compound 8
(β-sitosterol-3-O-β-D-glucopyranoside) (Beltrame et al., 2002; Kim
et al., 2003) and arjunolic acid (Thiagarajan et al., 2010). The diameter
of the inhibition zone for the EtOAc extract observed in the present
work (10 mm) was comparable with that measured by Bumrela and
Naik (2011) while studying the methanolic extract from the leaves of
Dipteracanthus patulus, for which they claimed a direct association be-
tween the presence of β-sitosterol and the antimicrobial activity. The
activity of β-sitosterol-3-O-β-D-glucopyranoside in a disk diffusion
test has never been evaluated. Available data are fromminimal inhibito-
ry concentration (MIC) determinations (Kim et al., 2003). β-Sitosterol-
3-O-β-D-glucopyranoside was active only against Gram-positive bacte-
ria with MICs of 50–400 mg/l. S. aureuswas intermediately susceptible
with an MIC equal to 200 mg/l. Therefore β-sitosterol-3-O-β-D-
glucopyranoside could contribute to the observed antibacterial activity.
Conversely, there was not ameasurable activity either for themethano-
lic extract or for the butanolic or the aqueous extracts. The absence of
antibiotic activity by the former could be explained by the lower
amount of active compounds contained in it, relative to the extracts ob-
tained in the subsequent ethyl acetate step. A proposed mechanism of
action for β-sitosterol activity has been the inhibition of the bacterial
deformylase (Hoskeri et al., 2012). The bacterial sortase seems to be
the molecular target for the action of the β-sitosterol-3-O-β-D-
glucopyranoside (Kim et al., 2003).
3.3. Antioxidant activity
The DPPH radical assay is a suitable model for estimating the total
antioxidant potential of antioxidants (Huang et al., 2005). Table 1
shows the DPPH radical scavenging activities of different extracts of
D. thollonii. All extracts have antioxidant activity against DPPH and the
reducing power of the n-BuOH extract exhibits the highest scavenging
activity. The IC50 values, deﬁned as the concentration of samples reduc-
ing 50% of free radical DPPH were calculated. According to these IC50
values, the DPPH radical scavenging ability was found in the order of
Trolox N n-BuOH N EtOAc NMeOH NWE (water extract). ABTS is anoth-
er widely used synthetic radical for both the polar and non-polar
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Fig. 1. Chemical structures of compounds isolated from the roots of D. thollonii Cogn.
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ent extracts of D. thollonii were also evaluated and reported in Table 1.
Also for this assay, the n-BuOH extract exhibits a maximum scavenging
activity. The IC50 values of the scavenging activities of the different
extracts were evaluated and the order of ABTS radical scavenging
ability is similar to that reported for DPPH assay and was Trolox NTable 1
Total antioxidant capacity of crude MeOH, EtOAc, n-BuOH, and water extracts of D. thollonii Co
Extract DPPH
TEAC
(μmol TE/g)
IC50
(mg/ml)
MeOH 4.45 ± 1.24 5.97 ± 0.09
EtOAc 6.17 ± 0.81 4.12 ± 0.12
n-BuOH 12.07 ± 1.65 2.11 ± 0.10
Water extract 2.26 ± 0.29 11.2 ± 0.16
Trolox – (6.35 ± 0.8)10−3
TEAC = trolox equivalent antioxidant concentration.n-BuOH N MeOH N EtOAc N WE. The FRAP assay mainly depends on
the reducing capacity of Fe3+-Fe2+ conversion and serves as a signiﬁ-
cant indicator of its potential antioxidant activity. The antioxidant activ-
ities have been attributed to various reactions, binding of transition
metal ion catalysts, decomposition of peroxides, prevention of continu-
ous proton abstraction and radical scavenging activity (Baskar et al.,gn.
ABTS FRAP
TEAC
(μmol TE/g)
IC50
(μg/ml)
TEAC
(μmol TE/g)
5.63 ± 0.36 2.79 ± 0.11 1.31 ± 0.08
1.94 ± 0.10 8.03 ± 0.18 0.19 ± 0.01
6.66 ± 0.44 2.36 ± 0.10 2.52 ± 0.25
1.09 ± 0.05 14.32 ± 0.21 0.30 ± 0.01
– (3.93 ± 0.2)10−3 –
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pattern of reducing capacity of different extracts was found in the order
of n-BuOH NMeOH NWE N EtOAc. The differences observed about the
behavior of water and EtOAc extracts are quite similar. As earlier indi-
cated, the phytochemical analysis of roots of the EtOAc extract has led
to the isolation of compounds 1, 4, 5, 7, 8 and 9 while in the n-BuOH
fractions the compounds isolated were 2, 3, 6, 10, 11 and 12. All these
secondary metabolites are known compounds present in other plants
used also in traditional medicine but herein isolated and reported for
the ﬁrst time in the roots of D. thollonii. Their isolation in large amount
probably plays an important role on the medicinal properties of this
plant material. The antioxidant activity determined on a different ex-
tract followed by fractionation and isolation reﬂects the properties of
the main components isolated. The antioxidant properties of the com-
pounds isolated from the EtOAc extract of D. thollonii have previously
been reported in different other plant extracts. These included 3,3′-di-
O-méthylellagic acid 4′-O-β-D-xylopyranoside 1(Khallouki et al.,
2007), betulinic acid 4 (De Souza et al., 2011; Yogeeswari and Sriram,
2005; Adesanwo et al., 2013), β-sitosterol 3-O-β-D-glucopyranosyl-6′-
mirystate 5 (Wangensteen et al., 2013), β-sitosterol 7 (Rao et al.,
2013; Gupta et al., 2011; Rajanandh and Kavitha, 2010), β-sitosterol-
3-O-β-D-glucopyranoside 8 (Rajanandh and Kavitha, 2010) and
arjunolic acid 9 (Sai et al., 2010). The synergic action of these com-
pounds could contribute to the antioxidant activity observed and we
can hypothesizedthat a large contribution is assigned to the presence
of β-sitosterol, betulinic acid and arjunolic acid for which more impor-
tant properties and biological activities have been reported (Rao et al.,
2013; Gupta et al., 2011; Rajanandh and Kavitha, 2010; Sai et al.,
2010; Thiagarajan et al., 2010). As reported in Table 1, the highest anti-
oxidant activity was demonstrated in the n-BuOH extract; therefore,
the repeated column chromatography of this extract followed by puriﬁ-
cation on silica gel and sephadex LH-20 columns afforded six known
compounds amongst which some have been reported with potentFig. 2. Inﬂuence of different extracts of D. thollonii on NO production (determined as nitrite via
tracts at different concentrations for 24 h. a) Methanol extract; b) n-butanol extract; c) ethyl a
means ± SD of three independent experiments. *p b 0.01, sample vs LPS-treated group; Dunnantioxidant activities namely 3,3′-O-dimethylellagic acid 4′-O-β-
D-xylopyranoside 1 (Zengjun et al., 2011), casuarinin 3 (Cheng et al.,
2003; Liu et al., 2004) and ellagic acid (Hayes et al., 2011; Fukuda
et al., 2003; Soong and Barlow, 2005). Derivatives of ellagic acid and
β-sitosterol probably with synergistic or additive effects are also re-
sponsible for the total antioxidant activity observed for the n-BuOH ex-
tract of D. thollonii. It could be deduced from these results that the
important antioxidant activities observed in the initial crude MeOH ex-
tract are recovered in the n-BuOH part, where important antioxidant
components have been characterized; especially casuarinin 3, which
has been obtained in large amount (914 mg) and seems to represent
one of the main components of the root of this plant.
3.4. Anti-inﬂammatory activity
3.4.1. Effects of D. thollonii extracts on LPS-induced NO production and cell
viability
The potential anti-inﬂammatory properties of D. thollonii extracts
were investigated using RAW 264.7 murine macrophage cells. Cells
were stimulated by 1 μg/ml lipopolysaccharide (LPS) and the effect of
extracts during a co-incubation period of 24 h was determined by
using NO production as ﬁnal read-out parameter. Validity of the assays
was shown by using untreated cells as negative control, LPS-stimulated
cells as positive control and additionally a cell group as reduction con-
trol group with LPS-stimulated cells, co-incubated together with
aminoguanidine, an inhibitor of iNOS (Koh et al., 2009) (Fig. 2). As
shown in Fig. 2a, the MeOH extract reduced the stimulated NO produc-
tion in a concentration-dependent manner of about 86% at the highest
tested concentration of 100 μg/ml (IC50= 5.9 μg/ml). During the inves-
tigation of other extracts derived from the MeOH extract, it was
established that the n-BuOH extract showed the highest dose depen-
dent reduction of NO formation (IC50 = 6.5 μg/ml; Fig. 2b) compared
to the EtOAc extract (IC50 = 18.1 μg/ml; Fig. 2c) whereas the waterGriess reaction) of RAW 264.7 macrophages after co-incubation with LPS 1 μg/ml, and ex-
cetate extract; d) aqueous extract. LPS, lipopolysaccharide. AG, aminoguanidine. Data are
ett multiple comparisons test.
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theMeOH extract and the other derived extracts did not have any inﬂu-
ence on the cell viability of the macrophages within the test concentra-
tions used (data not shown).
The phytochemical analysis of the root extracts of D. thollonii led to
the isolation and characterization of compounds with previously de-
scribed anti-inﬂammatory activity. Indeed, ellagic acid (compound 11)
has been reported as an effective anti-inﬂammatory agent in the
carrageenan-induced rat paw edema, with a prolonged onset and dura-
tion of action (Corbett et al., 2010). Another research also revealed
that ellagic acid took an important part in the anti-inﬂammatory,
antiedematous and analgesic effects of the extract of Lafoensia pacari
St. Hil. (Lythraceae) (Rogerio et al., 2006).Moreover, ellagic acid inhibits
PGE2 released in human monocytes (Karlsson et al., 2010) and inhibits
NO production in LPS-stimulated RAW 264.7 cells (Yang et al., 2011).
Compound 1 (3,3′-di-O-methylellagic acid 4′-O-β-D-xylopyranoside)
was shown to exert anti-inﬂammatory activity as reported by Sgariglia
et al. (2013). Compound 10 (3,3′-di-O-methylellagic acid) has been
reported as an inhibitor of Hyal and iNOS, reaching the 90% inhibitory
concentration (IC90) at values between 2.8 and 16.4 μM, which are
higher than the positive controls aspirin (IC90: no reached) and
aminoguanidine (IC90: 20.2 μM) (Sgariglia et al., 2013). Compound 3
(casuarinin) inhibits the IkB kinase, which is involved in the activation
of NFkB, and the increase of inducible nitric oxide synthase levels
in LPS-stimulated RAW 264.7 cells (Pan et al., 2000). Compound 4
(betulinic acid) had anti-inﬂammatory activities in carrageenan-
treated mice and LPS-treated RAW 264.7 cells (Steinkamp-Fenske
et al., 2007; Recio et al., 1995). β-Sitosterol 7 and β-sitosterol-3-O-β-
D-glucopyranoside 8 have also been reported to exhibit anti-
inﬂammatory activities (Perez, 2001). Moreover, compound 7 (β-sitos-
terol) down-regulates some pro-inﬂammatory signal transduction
pathway in murine macrophages and decreased disease incidence by
reducing the presence and inﬂammatory activity of macrophages in
the brains of treatedmice (Valerio and Awad, 2011; Valerio et al., 2011).
4. Conclusion
It is established from this study that most of the isolated compounds
from the different extracts of D. thollonii have previously revealed po-
tent antioxidant, antimicrobial and anti-inﬂammatory activities. It
could then be concluded that the biological and phytochemical charac-
terization of the root extracts of D. thollonii is supportive of the use of
this plant for the treatment of inﬂammation and sinusitis, thus provid-
ing evidence that this plant extracts might be potential sources of new
antioxidant and anti-inﬂammatory drugs.
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